At the time of writing, Biolife Solutions Inc [BLFS] stock is trading at $27.77, up 2.32%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BLFS shares have gain 6.40% over the last week, with a monthly amount glided 3.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biolife Solutions Inc [NASDAQ: BLFS] stock has seen the most recent analyst activity on September 30, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $29. Previously, Jefferies started tracking the stock with Buy rating on April 04, 2024, and set its price target to $22. On July 11, 2023, Craig Hallum initiated with a Buy rating and assigned a price target of $29 on the stock. Oppenheimer upgraded its rating to a Outperform but stick to its price target of $28 on April 25, 2022. B. Riley Securities initiated its recommendation with a Buy and recommended $61 as its price target on October 19, 2021. In a note dated May 14, 2021, The Benchmark Company downgraded an Hold rating on this stock.
For the past year, the stock price of Biolife Solutions Inc fluctuated between $14.50 and $29.55. Currently, Wall Street analysts expect the stock to reach $30 within the next 12 months. Biolife Solutions Inc [NASDAQ: BLFS] shares were valued at $27.77 at the most recent close of the market. An investor can expect a potential return of 8.03% based on the average BLFS price forecast.
Analyzing the BLFS fundamentals
According to Biolife Solutions Inc [NASDAQ:BLFS], the company’s sales were 123.36M for trailing twelve months, which represents an -8.27% plunge. Gross Profit Margin for this corporation currently stands at 0.46% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.26%, and Net Profit Margin reading is -0.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.14 and Total Capital is -0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.05 points at the first support level, and at 26.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.23, and for the 2nd resistance point, it is at 28.70.
Ratios To Look Out For
It is important to note that Biolife Solutions Inc [NASDAQ:BLFS] has a current ratio of 2.78. As well, the Quick Ratio is 1.78, while the Cash Ratio is 0.75. Considering the valuation of this stock, the price to sales ratio is 10.44, the price to book ratio is 3.94.
Transactions by insiders
Recent insider trading involved Mathew Aby J., EVP & Chief Scientific Officer, that happened on Feb 12 ’25 when 92.0 shares were sold. Chief Financial Officer, Wichterman Troy completed a deal on Feb 12 ’25 to sell 159.0 shares. Meanwhile, Chief Quality and Operations Foster Karen A. sold 78.0 shares on Feb 12 ’25.
